Expediting Drug Development — The FDA's New “Breakthrough Therapy” Designation

Title
Expediting Drug Development — The FDA's New “Breakthrough Therapy” Designation
Authors
Keywords
-
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 369, Issue 20, Pages 1877-1880
Publisher
New England Journal of Medicine (NEJM/MMS)
Online
2013-11-14
DOI
10.1056/nejmp1311439

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search